Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Characterization of long-term/short-term treatment duration in light Meeting Abstract

  

Authors:	Liu, Y.; Mathews, C.; Simpkins, F.; Cadoo, K.; Provencher, D.; McCormick, C.; Einaggar, A.; Altman, A.; Gilbert, L.; Black, D.; Kabil, N.; Taylor, R.; Barnicle, A.; Munley, J.; Aghajanian, C.
Abstract Title:	Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Characterization of long-term/short-term treatment duration in light
Meeting Title:	IGCS 2022 Annual Meeting
Journal Title:	International Journal of Gynecological Cancer
Volume:	32
Issue:	Suppl. 3
Meeting Dates:	2022 Sep 29-Oct 1
Meeting Location:	New York, NY
ISSN:	1048-891X
Publisher:	Lippincott Williams & Wilkins
Date Published:	2022-12-01
Start Page:	A156
End Page:	A157
Language:	English
ACCESSION:	WOS:000899252300323
DOI:	10.1136/ijgc-2022-igcs.354
PROVIDER:	wos
Notes:	Meeting Abstract: EP263/#849 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/205307